Purpose. To evaluate the refractive and the quality of vision outcomes of toric IOL implantation in patients with low astigmatism. Design. Prospective study of single-arm. Methods. Patients with corneal astigmatism range from 0,75 D to 1,5 D and cataract that underwent cataract surgery with toric IOL. The measurements were performed preoperatively and 6 weeks after the surgery. Patients were evaluated for visual acuity with and without correction, contrast sensitivity, static and dynamic refraction, and quality of life questionnaire. Pre- and postoperative values were compared and their variations were evaluated for linear correlation. Results. 21 eyes of 21 patients. Postoperative mean uncorrected visual acuity was 0.80 ± 0.19, and the best corrected visual acuity was 0.97 ± 0.15. p < 0.001 compared to preoperative values. The average postoperative refractive cylinder was −0.34 ± 0.39. The questionnaire's total value before and after surgery was, respectively, 43.20 ± 15.76 and 79.70 ± 10.11 (p < 0.001). The correlation coefficients between the values of the questionnaire variation and the UCVA, BCVA, and CS variation were, respectively, 0.548 (p = 0.005), 0.508 (p = 0.009), and 0.409 (p = 0.033). Conclusion. Patients with low astigmatism who underwent phacoemulsification with toric IOL implantation experienced significant decrease in refractive astigmatism and improvement in their quality of life.
PurposeTo report a case of a young patient with retinitis pigmentosa (RP), essential iris atrophy, and glaucoma.Case reportThis report presents a case of a 22-year-old female patient with unilateral glaucoma, increased intraocular pressure, increased cup–disc ratio, iris atrophy, peripheral anterior synechiae, and bilateral RP.DiscussionThe patient presented glaucoma due to the iridocorneal endothelial syndrome, despite low age. RP is a bilateral disorder that may be associated with angle-closure glaucoma.
RESUMOObjetivo: Identificar causas relacionadas com a não aderência ao tratamento do glaucoma primário de ângulo aberto e sugerir meios para posteriormente minimizá-las. Métodos: Foi aplicado um questionário a pacientes portadores de glaucoma primário de ângulo aberto no Hospital Universitário Gaffrée e Guinle, escolhidos aleatoriamente, para avaliação dos fatores relacionados com a interrupção do tratamento. Para isso, utilizou-se uma análise univariada, pelo teste exato de Fisher, e considerou estatisticamente significativo p<0,05. Resultados: A partir do questionário, identificou-se dois subgrupos, um que já havia interrompido o tratamento e outro que nunca o havia interrompido, compostos por 25 e 11 pacientes respectivamente. Estes grupos foram comparados entre si e todos os parâmetros analisados. O custo dos medicamentos (p=0,001) e o fator esquecimento (p=0,007) foram estatisticamente relevantes para a interrupção do tratamento da doença. As demais variáveis testadas não obtiveram significância estatística. Conclusão: O custo dos medicamentos e o fator esquecimento foram os fatores mais importantes para interrupção do tratamento.Descritores: Glaucoma/terapia; Adesão ao tratamento; Glaucoma primário de ângulo aberto/terapia; Custos de medicamentos; Suspensão de tratamento ABSTRACTThe objective was to identify causes related to noncompliance of primary open-angle glaucoma and suggest ways to minimize them later. A questionnaire was given to patients with primary open angle glaucoma in Hospital Gaffrée Guinle, chosen randomly, to assess factors related to discontinuation of treatment. For this we used a univariate analysis by Fisher's exact test and considered statistically significant p <0.05. From the questionnaire, we identified two sub-groups, who had stopped treatment and another who had never stopped for 25 compounds and 11 patients respectively. These groups were compared, and all parameters examined. The cost of drugs (p = 0.001) and forgetting factor (p = 0.007) were statistically significant for discontinuation of treatment of disease. The other variables tested did not achieve statistical significance. Conclusion: The cost of drugs and forgetting to take medication were the factors most important to withholding treatment
RESUMOA Síndrome de Tolosa Hunt é uma doença rara, cuja etiopatogenia é desconhecida. Apresenta-se como uma oftalmoplegia dolorosa de um ou mais nervos cranianos oculomotores, que regride espontaneamente e responde bem ao tratamento com corticoides. O presente estudo trata-se de um relato de caso de um paciente que apresentou seguidos casos de oftalmoplegias dolorosas, envolvendo o nervo oculomotor e o abducente sendo tratado com corticoesteroides obteve uma resposta dramática. Objetiva-se ainda descrever as características fisiopatológicas, clínicas, o diagnóstico diferencial, visto que é um diagnóstico de exclusão, e medidas terapêuticas instituídas de acordo com o International Headache Society 2004 (ISH-2004 através da apresentação do caso clínico conduzido com as normas do estudo supracitado.Descritores: Síndrome de Tolosa-Hunt/diagnóstico; Oftalmoplegia/quimioterapia; Prednisona/uso terapêutico; Dor/classificação; Classificação Internacional de Doenças; Relato de casos
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.